spacer
spacer

Jump to: InterProScan Databases Documentation FTP site Help Advanced search

InterPro: IPR011040 Neuraminidase

Protein matchesHelp
UniProtKB
Matches:
17467 proteins
AccessionHelp IPR011040 Neuraminidase
TypeHelp Domain
SignaturesHelp
InterPro RelationshipsHelp
Found in IPR000665 Haemagglutinin-neuraminidase glycoprotein
IPR001860 Glycoside hydrolase, family 34
IPR008377 Trypanosome sialidase
IPR016285 Haemagglutinin-neuraminidase, paramyxovirus
Contains IPR002860 BNR repeat
IPR015344 Vibrio cholerae sialidase, lectin insertion
InterPro annotation
BioMart Logo Entry Details in BioMart
AbstractHelp

Neuraminidases (sialidases) hydrolyse the non-reducing, terminal sialic acid linkage in various natural substrates, such as glycoproteins, glycolipids, gangliosides, and polysaccharides [1]. In mammals, neuraminidases occur in the lysosome, the cytosol, and associated with the plasma membrane. Neuraminidases have also been implicated in the pathogenesis of many diseases. For example, in viruses neuraminidases enable the transport of the virus through mucin, the eruption of the virus from the infected host cell, and the prevention of self-aggregation of virus particles through the destruction of the host cell receptor recognised by the virus [2]. Eukaryotic, bacterial and viral neuraminidases share highly conserved regions of beta-sheet motifs. Bacterial neuraminidases often possess domains in addition to the catalytic neuraminidase domain, for instance the neuraminidase from Micromonospora viridifaciens contains three domains, of which the catalytic domain described here is the N-terminal domain [3]. Similarly, leech neuraminidase is a multidomain protein, where the catalytic domain is the C-terminal domain [4]. In several paramyxoviruses, neuraminidase forms part of the multi-functional haemagglutinin-neuraminidase glycoprotein found on the viral envelope [5].

Structural linksHelp
PDB - click here
SCOP: b.29.1.8 , b.68.1.1
Database linksHelp
Enzyme: EC:3.2.1.18

Taxonomic coverageHelp

Overlapping InterPro entriesHelp
IPR011040 Numbers of overlapping proteins Average numbers of overlapping amino acids

Example proteinsHelp
O89343 Glycoprotein G

P0C6E9 Sialidase

P25606 Uncharacterized protein YCR100C

Q60841 Reelin

Q9Y3R4 Sialidase-2

More proteins


Example Proteins Key


InterPro entry accession number/name and structure databases Colour code
IPR016285 Haemagglutinin-neuraminidase, paramyxovirus
IPR002861 Reeler domain
IPR013320 Concanavalin A-like lectin/glucanase, subgroup
IPR013111 EGF, extracellular
IPR006210 EGF-like
IPR000665 Haemagglutinin-neuraminidase glycoprotein
IPR015344 Vibrio cholerae sialidase, lectin insertion
IPR000742 EGF-like, type 3
IPR013032 EGF-like region, conserved site
IPR011040 Neuraminidase
IPR008985 Concanavalin A-like lectin/glucanase
PDB Chain
ModBase
CATH Domain
SWISS-MODEL
SCOP Domain

PublicationsHelp
1. Monti E, Preti A, Venerando B, Borsani G.
Recent development in mammalian sialidase molecular biology.
Neurochem. Res. 27 649-63 2002 [PubMed: 12374200]
http://dx.doi.org/10.1023/A:1020276000901
2. Johansson BE, Brett IC.
Variation in the divalent cation requirements of influenza a virus N2 neuraminidases.
J. Biochem. 134 345-52 2003 [PubMed: 14561719]
http://dx.doi.org/10.1093/jb/mvg151
3. Gaskell A, Crennell S, Taylor G.
The three domains of a bacterial sialidase: a beta-propeller, an immunoglobulin module and a galactose-binding jelly-roll.
Structure 3 1197-205 1995 [PubMed: 8591030]
http://dx.doi.org/10.1016/S0969-2126(01)00255-6
4. Luo Y, Li SC, Li YT, Luo M.
The 1.8 A structures of leech intramolecular trans-sialidase complexes: evidence of its enzymatic mechanism.
J. Mol. Biol. 285 323-32 1999 [PubMed: 9878409]
http://dx.doi.org/10.1006/jmbi.1998.2345
5. Lawrence MC, Borg NA, Streltsov VA, Pilling PA, Epa VC, Varghese JN, McKimm-Breschkin JL, Colman PM.
Structure of the haemagglutinin-neuraminidase from human parainfluenza virus type III.
J. Mol. Biol. 335 1343-57 2004 [PubMed: 14729348]
http://dx.doi.org/10.1016/j.jmb.2003.11.032

Additional ReadingHelp
Luo M.
Structural biology: antiviral drugs fit for a purpose.
Nature 443 2006 37-8 [PubMed: 16915238]
http://dx.doi.org/10.1038/nature05003
Watts AG, Oppezzo P, Withers SG, Alzari PM, Buschiazzo A.
Structural and kinetic analysis of two covalent sialosyl-enzyme intermediates on Trypanosoma rangeli sialidase.
J. Biol. Chem. 281 2006 4149-55 [PubMed: 16298994]
http://dx.doi.org/10.1074/jbc.M510677200
Smith BJ, Huyton T, Joosten RP, McKimm-Breschkin JL, Zhang JG, Luo CS, Lou MZ, Labrou NE, Garrett TP.
Structure of a calcium-deficient form of influenza virus neuraminidase: implications for substrate binding.
Acta Crystallogr. D Biol. Crystallogr. 62 2006 947-52 [PubMed: 16929094]
http://dx.doi.org/10.1107/S0907444906020063
Venkatramani L, Bochkareva E, Lee JT, Gulati U, Graeme Laver W, Bochkarev A, Air GM.
An epidemiologically significant epitope of a 1998 human influenza virus neuraminidase forms a highly hydrated interface in the NA-antibody complex.
J. Mol. Biol. 356 2006 651-63 [PubMed: 16384583]
http://dx.doi.org/10.1016/j.jmb.2005.11.061
Buchini S, Buschiazzo A, Withers SG.
A new generation of specific Trypanosoma cruzi trans-sialidase inhibitors.
Angew. Chem. Int. Ed. Engl. 47 2008 2700-3 [PubMed: 18300214]
spacer
spacer
InterPro 23.1